Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy: A randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono)

Vivian A. Fonseca; Ricardo Alvarado-Ruiz; Denis Raccah; Gabor Boka; Patrick Miossec; John E. Gerich; on behalf of the EFC6018 GetGoal-Mono Study Investigators

doi:10.2337/dc11-1935

Original Research

Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy

A randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono)

Vivian A. Fonseca, MD¹ ⇓,
Ricardo Alvarado-Ruiz, MD²,
Denis Raccah, MD³,
Gabor Boka, MD⁴,
Patrick Miossec, MD⁵,
John E. Gerich, MD⁶ and
on behalf of the EFC6018 GetGoal-Mono Study Investigators

¹Department of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana
²Cardioprevent, Durango, Mexico
³Department of Diabetology, University Hospital Sainte Marguerite, Marseille, France
⁴Sanofi R&D, Chilly-Mazarin, France
⁵Sanofi R&D, Paris, France
⁶Department of Medicine, University of Rochester School of Medicine, Rochester, New York

Corresponding author: Vivian A. Fonseca, vfonseca{at}tulane.edu.

Diabetes Care 2012 Jun; 35(6): 1225-1231. https://doi.org/10.2337/dc11-1935

Article Information

vol. 35 no. 6 1225-1231

DOI

https://doi.org/10.2337/dc11-1935

PubMed

22432104

Published By

American Diabetes Association

Print ISSN

0149-5992

Online ISSN

1935-5548

History

Received October 5, 2011
Accepted February 10, 2012
Published in print May 22, 2012.
Published online ahead of print March 19, 2012.

Article Versions

Previous version (March 19, 2012 - 12:38).
You are viewing the most recent version of this article.

© 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

Author Information

Vivian A. Fonseca, MD¹ ⇓,
Ricardo Alvarado-Ruiz, MD²,
Denis Raccah, MD³,
Gabor Boka, MD⁴,
Patrick Miossec, MD⁵,
John E. Gerich, MD⁶ and
on behalf of the EFC6018 GetGoal-Mono Study Investigators

¹Department of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana
²Cardioprevent, Durango, Mexico
³Department of Diabetology, University Hospital Sainte Marguerite, Marseille, France
⁴Sanofi R&D, Chilly-Mazarin, France
⁵Sanofi R&D, Paris, France
⁶Department of Medicine, University of Rochester School of Medicine, Rochester, New York

Corresponding author: Vivian A. Fonseca, vfonseca{at}tulane.edu.

View Full Text

Statistics from Altmetric.com

Article usage

Article usage: March 2012 to February 2021

Rendering graph...

	Abstract	Full	Pdf
Mar 2012	690	0	146
Apr 2012	627	0	175
May 2012	2833	30	189
Jun 2012	3683	77	215
Jul 2012	1061	41	98
Aug 2012	716	43	54
Sep 2012	609	149	77
Oct 2012	443	205	69
Nov 2012	331	192	76
Dec 2012	216	102	52
Jan 2013	320	203	57
Feb 2013	335	323	88
Mar 2013	306	293	75
Apr 2013	388	303	79
May 2013	324	234	80
Jun 2013	261	101	143
Jul 2013	195	99	91
Aug 2013	240	84	51
Sep 2013	145	86	66
Oct 2013	190	86	60
Nov 2013	186	66	93
Dec 2013	112	64	67
Jan 2014	129	77	78
Feb 2014	113	60	62
Mar 2014	100	62	90
Apr 2014	107	53	85
May 2014	80	52	74
Jun 2014	71	49	81
Jul 2014	128	56	54
Aug 2014	79	26	50
Sep 2014	70	61	75
Oct 2014	73	26	42
Nov 2014	67	23	39
Dec 2014	79	16	29
Jan 2015	67	27	35
Feb 2015	49	24	17
Mar 2015	63	49	42
Apr 2015	82	50	39
May 2015	72	38	42
Jun 2015	82	28	60
Jul 2015	64	25	37
Aug 2015	51	29	44
Sep 2015	102	46	40
Oct 2015	59	30	22
Nov 2015	65	30	34
Dec 2015	59	23	39
Jan 2016	59	27	35
Feb 2016	61	19	43
Mar 2016	107	32	30
Apr 2016	50	17	35
May 2016	48	82	49
Jun 2016	22	50	37
Jul 2016	17	65	35
Aug 2016	41	114	63
Sep 2016	49	113	43
Oct 2016	56	108	75
Nov 2016	38	117	59
Dec 2016	18	46	39
Jan 2017	36	81	43
Feb 2017	29	93	55
Mar 2017	17	70	12
Apr 2017	11	70	22
May 2017	10	80	56
Jun 2017	12	76	25
Jul 2017	12	57	34
Aug 2017	10	43	16
Sep 2017	6	37	17
Oct 2017	6	83	26
Nov 2017	16	67	29
Dec 2017	11	45	8
Jan 2018	25	48	15
Feb 2018	40	40	19
Mar 2018	22	35	11
Apr 2018	16	159	31
May 2018	5	83	14
Jun 2018	14	88	24
Jul 2018	18	74	28
Aug 2018	8	108	14
Sep 2018	6	41	11
Oct 2018	4	59	16
Nov 2018	16	81	21
Dec 2018	10	42	14
Jan 2019	11	36	9
Feb 2019	8	48	16
Mar 2019	8	41	16
Apr 2019	5	25	22
May 2019	12	31	15
Jun 2019	15	25	21
Jul 2019	13	25	18
Aug 2019	3	21	10
Sep 2019	12	34	23
Oct 2019	10	40	15
Nov 2019	5	32	17
Dec 2019	14	21	15
Jan 2020	13	25	17
Feb 2020	20	41	12
Mar 2020	17	15	7
Apr 2020	10	21	6
May 2020	16	21	25
Jun 2020	9	14	24
Jul 2020	13	32	12
Aug 2020	12	24	9
Sep 2020	12	25	13
Oct 2020	15	28	14
Nov 2020	23	29	22
Dec 2020	16	51	16
Jan 2021	19	40	15
Feb 2021	13	49	15